,created_at,~,text,~.1,location,~.2,name,textnew,lang
4,24/07/2020 18:47,~,"RT @BudRante: $SRNE  DEFIES  BEAR STREET GRAVITY
2  #COVID19 ACQUISITIONS IN 1 WK
GAME CHANGER
#COVID19 PREVAILS ON A TIGHT GRIP #STI1499 ,…",~,Las Vegas,~,BudRante,"  $SRNE  DEFIES  BEAR STREET GRAVITY
   ACQUISITIONS IN  WK
GAME CHANGER
 PREVAILS ON A TIGHT GRIP  ,…",en
5,24/07/2020 17:46,~,"$SRNE  DEFIES  BEAR STREET GRAVITY
2  #COVID19 ACQUISITIONS IN 1 WK
GAME CHANGER
#COVID19 PREVAILS ON A TIGHT GRIP… https://t.co/nRcCSqXO1y",~,Las Vegas,~,BudRante,"$SRNE  DEFIES  BEAR STREET GRAVITY
   ACQUISITIONS IN  WK
GAME CHANGER
 PREVAILS ON A TIGHT GRIP… ",en
7,29/07/2020 08:59,~,@JacobPlieth And Abivax with Abx464: NCT04393038,~,"Albuquerque, NM",~,PaulGoodman75, And Abivax with Abx NCT,en
9,25/07/2020 07:56,~,"@PPouletty must be corrected on one point: $ABVX is not a biotechnology company, but an innovative pharmaceutical c… https://t.co/fFJDT3Zf9F",~,Germany,~,GermanBiotech," must be corrected on one point $ABVX is not a biotechnology company, but an innovative pharmaceutical c… ",en
16,26/07/2020 15:03,~,"RT @chill93til: Started this NAC today. I feel more alert but it hasn't been long really so maybe it's a placebo effect. Time will tell.

N…",~,,~,Justin__2015,"  Started this NAC today. I feel more alert but it hasn't been long really so maybe it's a placebo effect. Time will tell.

N…",en
17,26/07/2020 08:34,~,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, r… https://t.co/KCU8Ah7IXC",~,"Jupiter, FL",~,HealthyBuilds,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis An open-label, r… ",en
18,26/07/2020 08:34,~,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, r… https://t.co/515PSogJnM",~,,~,SandersFilters,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis An open-label, r… ",en
19,26/07/2020 08:34,~,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, r… https://t.co/le9CEbnXoy",~,"Jupiter, FL",~,NanoSafe1,"Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis An open-label, r… ",en
20,25/07/2020 22:47,~,Started this NAC today. I feel more alert but it hasn't been long really so maybe it's a placebo effect. Time will… https://t.co/hTwu38TAMM,~,elsewhere,~,chill93til,Started this NAC today. I feel more alert but it hasn't been long really so maybe it's a placebo effect. Time will… ,en
21,25/07/2020 18:36,~,RT @cmencke: AwesomeCapital: Intravenous n-acetylcysteine blocks inflammation i... https://t.co/fxhbz1yFpS,~,,~,cmencke,  AwesomeCapital Intravenous n-acetylcysteine blocks inflammation i... ,en
22,25/07/2020 18:36,~,AwesomeCapital: Intravenous n-acetylcysteine blocks inflammation i... https://t.co/fxhbz1yFpS,~,,~,cmencke,AwesomeCapital Intravenous n-acetylcysteine blocks inflammation i... ,en
23,21/07/2020 22:35,~,Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice https://t.co/Ty8RkWDAvo,~,"Hyderabad, India",~,hscelebrities,Antioxidant Effects of N-Acetylcysteine Prevent Programmed Metabolic Disease in Mice ,en
25,29/07/2020 11:10,~,Study Confirms Safety and Efficacy of BI's #Humira #Biosimilar https://t.co/5q7WBllsUI via @BiosimCenter  @Boehringer #adalimumab #Cyltezo,~,267-337-7038,~,PlexusVentures,Study Confirms Safety and Efficacy of BI's    via     ,en
26,28/07/2020 19:28,~,"@JNiaura @Dereklowe Well CAT ""made"" adalimumab didn't they? And BASF sold it for a pittance... Humira is easily wor… https://t.co/P9CSohivLE",~,,~,SnupSnus,"  Well CAT ""made"" adalimumab didn't they? And BASF sold it for a pittance... Humira is easily wor… ",en
27,28/07/2020 16:55,~,"A phase 3b clinical trial, as part of @AADskin's #AADVMX2020 assessing @Boehringer's adalimumab #biosimilar (Cyltez… https://t.co/zZS1N6v6Lh",~,"Cranbury, NJ",~,BiosimCenter,"A phase b clinical trial, as part of 's  assessing 's adalimumab  (Cyltez… ",en
